A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

OBJECTIVE: Phosphodiesterase 4 inhibitors (PDE4i) are novel anti-inflammatory medications that have been approved for rheumatologic diseases and have been tested as host-directed therapy in tuberculosis. We examined the safety of CC-11050, a potent PDE4i in people living with HIV (PLWH) with suppres...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Boulougoura, Afroditi, Gabriel, Erin, Laidlaw, Elizabeth, Khetani, Vikram, Arakawa, Ken, Higgins, Jeanette, Rupert, Adam, Gorelick, Robert J, Lumbard, Keith, Pau, Alice, Poole, April, Kibiy, Angela, Kumar, Princy, Sereti, Irini
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Editor's Choice
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6559277/
https://ncbi.nlm.nih.gov/pubmed/31211164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz246
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares